MEVOKED and PHQ9 Data

Overview

About this study

Data collected from the MEVOKED Study #1 (IRB#14-009159) showed wide variability in how participants engaged with and used the MEVOKED program. This study will obtain additional information on participants – in particular PHQ9 depression scores and medication use during their enrollment in the MEVOKED program will provide additional data to support the analysis of the MEVOKED Study #1 (IRB#14-009159).

Participation eligibility

Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and identify who can or cannot participate. There is no guarantee that every individual who qualifies and wants to participate in a trial will be enrolled. Contact the study team to discuss study eligibility and potential participation.

Inclusion Criteria:

Completed verbal enrollment in IRB #14-009159
Completed at least 6 weeks and one interview of the IRB #14-009159 study
Consent to have name and depression treatment information (phq9 score and psychiatric medication list) collected from their medical record and shared with research team and MEVOKED staff.

Exclusion Criteria:

None

Participating Mayo Clinic locations

Study statuses change often. Please contact the study team for the most up-to-date information regarding possible participation.

Mayo Clinic Location	Status
Rochester, Minn. Mayo Clinic principal investigator Kristin Vickers, Ph.D., L.P.	Closed for enrollment

Mayo Clinic Location

Status

Rochester, Minn.

Mayo Clinic principal investigator

Kristin Vickers, Ph.D., L.P.

Closed for enrollment

More information

Publications

Publications are currently not available

Clinical Trials